Massive changes have occurred over the last decade in the pharmaceutical industry andhave consequently led to a period of transition, which has necessitated a change in approach. The previous blockbuster model was showing cracks, and reps were no longer seen as the solution to a lot of problems. SMi’s CPD accredited Masterclassgives industry professionals an insight into the inner workings of pharmaceutical marketing and enables delegates to develop an in-depth understanding of the role that opinion leaders in the new pharmaceutical industry environment.
Based on extensive scientific research into communication dynamics, diffusion of innovations, word of mouth and marketing theory, the first part of our Masterclass deals with how this new approach is formulated and analyses the new factors (such as regulation and market access) that have altered the manner in which pharmaceutical marketing is conducted in the new millennium. Part Two of our Masterclass will provide an overview of themes like: opinion leader driven product adoption, role of OLs in diffusion marketing, and the role OLs in prevention of product discontinuance.
Benefits of attending SMi’s CPD accredited masterclass, New Pharmaceutical Marketing and Strategy in Opinion Leadership:
Upon completion of this Masterclass, through a combination of presentations and interactive discussion, you will:
Acquire an understanding of the role that opinion leaders have in the new pharmaceutical industry environment
Gainan insight into the specific workings of pharmaceutical marketing
Examine why the old pharmaceutical marketing was never really the answer and how the latest methods in pharmaceutical marketing are relevant in the new environment
Discuss the adaptations needed to survive in the new pharmaceutical marketing domain e.g. changes in understanding of opinion leadership and how to implement an opinion leader strategy
Assess the role of opinion leaders in the prevention of product discontinuance
Learn from extremely experienced lecturers with decades of experience a wide range of areas within the Pharmaceutical sector
For further information and the opportunity to register online please visit; www.smi-online.co.uk/2011pharmamarketing12.asp
The aim of SMi is Linking Business with Information through the delivery of high quality business to business information services. Our overriding advantage is our flexibility and ability to respond quickly to the requirements and needs of all our customers, ensuring that all SMi products are highly relevant, innovative and timely.
The SMi Group is a world leader in business to business information. Within the past year thousands of senior executives from blue chip companies benefited from SMi's highly targeted conferences, workshops and masterclasses.
As a market research based organisation, SMi takes pride in the quality of its programmes and documentation, ensuring that they are brought to the attention of the key decision makers in each industry sector in which it operates. We cultivate and maintain strong industry contacts to ensure that we are informed of all pending changes in government and regulatory policy, and we regard our relationships with speakers, delegates and subscribers as an investment for the future.